SOTERA HEALTH COMPANY Segment Expenditure Addition To Long Lived Assets
SOTERA HEALTH COMPANY (SHC) reported Segment Expenditure Addition To Long Lived Assets of $46.17 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-05-05
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $46.17M, a 131.78% increase year-over-year.
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for the quarter ending 2025-03-31 was $19.92M, a 42.91% decline year-over-year.
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for the quarter ending 2024-03-31 was $34.89M.
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for fiscal 2025 was $138.02M, a 22.93% decline from fiscal 2024.
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for fiscal 2024 was $179.07M, a 16.70% decline from fiscal 2023.
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for fiscal 2023 was $214.97M, a 17.87% increase from fiscal 2022.
- SOTERA HEALTH COMPANY segment expenditure addition to long lived assets for fiscal 2022 was $182.38M.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|
| 2026-03-31 | $46.17M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $138.02M 10-K · filed 2026-02-24 | |
| 2025-03-31 | $19.92M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $179.07M 10-K · filed 2026-02-24 | |
| 2024-03-31 | $34.89M 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $214.97M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $182.38M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |